Research ArticleArticle
Oxygen surrogate systems for supporting human drug-metabolizing cytochrome P450 enzymes
Silja J Strohmaier, James J De Voss, Ulrik Jurva, Shalini Andersson and Elizabeth M. J. Gillam
Drug Metabolism and Disposition April 1, 2020, dmd.120.090555; DOI: https://doi.org/10.1124/dmd.120.090555
Silja J Strohmaier
1 University of Queensland;
James J De Voss
1 University of Queensland;
Ulrik Jurva
2 DMPK, Early Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca;
Shalini Andersson
3 Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca
Elizabeth M. J. Gillam
1 University of Queensland;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Oxygen surrogate systems for supporting human drug-metabolizing cytochrome P450 enzymes
Silja J Strohmaier, James J De Voss, Ulrik Jurva, Shalini Andersson and Elizabeth M. J. Gillam
Drug Metabolism and Disposition April 1, 2020, dmd.120.090555; DOI: https://doi.org/10.1124/dmd.120.090555
Research ArticleArticle
Oxygen surrogate systems for supporting human drug-metabolizing cytochrome P450 enzymes
Silja J Strohmaier, James J De Voss, Ulrik Jurva, Shalini Andersson and Elizabeth M. J. Gillam
Drug Metabolism and Disposition April 1, 2020, dmd.120.090555; DOI: https://doi.org/10.1124/dmd.120.090555
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement